Skip to main content

Peer Review reports

From: Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease

Original Submission
23 Oct 2015 Submitted Original manuscript
22 May 2016 Author responded Author comments - Xin Yang
28 Mar 2016 Reviewed Reviewer Report - Alan Parrish
16 Dec 2015 Reviewed Reviewer Report - David Briskey
Resubmission - Version 2
22 May 2016 Submitted Manuscript version 2
2 Jul 2016 Author responded Author comments - Xin Yang
1 Jun 2016 Reviewed Reviewer Report - Alan Parrish
2 Jun 2016 Reviewed Reviewer Report - David Briskey
Resubmission - Version 3
2 Jul 2016 Submitted Manuscript version 3
12 Jul 2016 Author responded Author comments - Xin Yang
Resubmission - Version 4
12 Jul 2016 Submitted Manuscript version 4
Publishing
19 Jul 2016 Editorially accepted
26 Jul 2016 Article published 10.1186/s12906-016-1228-4

You can find further information about peer review here.

Back to article page
\